May 6, 2025
| Today’s news and insights for medtech leaders
Medical device manufacturers could face increased costs if the Commerce Department's Section 232 probe leads to tariffs on chips.
|
The orthopedics company lowered its earnings forecast, accounting for the tariffs and closing the acquisition of Paragon 28.
|
CEO Roy Jakobs said tariff impacts require the company to accelerate localization of production in the U.S.
|
Tracker
Policies and actions reshaping the healthcare industry began pouring out of President Donald Trump’s White House nearly from day one. Follow the changes affecting the medical device industry.
|
The medical technology company expects the new indication to increase sales in its transcatheter aortic valve replacement business with more patients becoming eligible for the treatment.
|
|
The playbook breaks down how, by planning for scalability and employing the right technology, you can successfully execute your next clinical trial.
|
|
From Our Library
Playbook
Custom content for Avania
|
Playbook
Custom content for PCI Pharma Services
|
Playbook
Custom content for Salesforce & Cognizant
|
Playbook
Custom content for Medmarc
|
Playbook
Custom content for Altium
|
View all resources
What We're Reading
| 
